Journal of reproductive health and uro-nephrology research (Репродуктив саломатлик ва уро-нефрологик тадқиқотлар журнали) 5-jild 1-son (2024)
THE EFFECTIVENESS OF TREATMENT OF ASCITES DUE TO RECURRENCE OF PLATINUM-REFRACTORY OVARIAN CANCER USING METRONOMIC CHEMOTHERAPY
Рахимов Нодир Махамматкулович, Шаханова Шахноза Шавкатовна, Абдурахмонов Журабек Амриллоевич, Талибова Нилуфар Актамовна, Сулимова Ольга Геннадьевна
Annotatsiya
Ovarian cancer (OC) remains the leading cause of death from gynecological cancer. The initial treatment for IC-IV stages of OC includes surgical cytoreduction followed by platinum-containing chemotherapy. The best outcomes are observed in patients, in whom complete cytoreduction has been achieved. Despite this fact, most patients develop relapses and the 5-year survival rate is about 30 %. The frequency of lymph node involvement in patients with recurrent OC is not reliably known; isolated lymph node recurrence is reported to occur in 5–32 % of patients. To date, the problem regarding the extent of lymph node dissection in treatment of OC recurrence is still unsolved. In our paper we review the available data concerning the role of secondary cytoreductive surgery for isolated lymph node recurrence of ovarian cancer. Isolated lymph node recurrence of ovarian cancer may indicate a more favorable prognosis and has a less aggressive pattern of OC relapse. The role of secondary cytoreduction in this context is not fully understood, but this category of patients may be one of the most suitable for surgical treatment of ovarian cancer recurrence.
рак яичников, лимфодиссекция, циторедукция, метастазирование, платиночувствительные и платинорезистентные рецидивы.ovarian cancer, lymph node dissection, cytoreduction, metastasis, platinum-sensitive and platinum-resistant recurrencetuxumdon saratoni, limfodissektsiya, sitoreduksiya, metastaz, platina sezgir va platinaga chidamli recidivlar
Metadata manbasi: jurnal OAI-PMH arxivi · Sindex toʻliq matnni saqlamaydi, manbaga havola beradi.